Global Geriatric Medicine Market Size was valued nearly USD 630,225.2 million by 2017 and is estimated to reach up to USD xx.xx million by 2025. According to latest study conducted by our analysts and industry experts, the global market is expected to grow at a CAGR of 6.1% during the forecast period that is 2017-2025. The geriatric Medicine a specialty that focuses on health care of elderly people. It aims to promote health by preventing and treating diseases and disabilities in older adults. There is no set age at which patients may be under the care of a geriatrician, or geriatric physician, a physician who specializes in the care of elderly people.

Global Market Growth Opportunities (Revenue, Growth) By 2017-2025

This global market study report analysis offers in-depth insights, revenue details, and other vital information regarding the global geriatric medicine market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2025. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global geriatric medicine market report has been segmented on the basis of type, application, and region. It includes the estimation of the market size, in terms of value, with respect to 4 main geographies, namely, North America, Europe, APAC, and RoW.

Market Dynamics

The global geriatric medicine market is estimated to value at USD 630,225.2 million in 2017. The market is expected to grow at a faster pace during the forecast period due to high presence of geriatric populations in many regions. According to the Industry Reports in United Nations 2012, the number of the geriatric population across the globe was approximately 809.4 million and is this anticipated to reach around 1.4 billion by 2030. Moreover, growing chronic conditions and the rising occurrence of chronic disorders such as cardiovascular disorder, rheumatoid arthritis and other bone-related problems, neurological disorders, and cancer cases amongst the geriatric population is another major factor boosting the growth of the geriatric medicines market.

Additionally, a number of geriatric populations reliant on polypharmacy are anticipated to develop side-effects due to the interactions of the diverse medicines. The increasing incidences of medication-related disorders among geriatrics and the critical necessity for proper care are the determining factors fueling the market growth.

However, the lack of awareness majorly in developing and low-income economies and side effects associated with the medicines are the factors anticipated to binder the market growth.

Segment Analysis 

On the basis of therapeutic category, the global geriatric medicines market is segmented into Analgesics, Antihypertensive, Statins, Antidiabetics, Proton Pump Inhibitor, Anticoagulant, Antipsychotic, and Antidepressant. Pain as an indication is associated with old age and the middle age population unveils the high occurrence rate of pain related syndromes. Based on current trends and the demand for proper therapy, the market is anticipated to witness high growth for therapeutic conditions during the forecast period.

On the basis of therapeutic conditions, the global geriatric medicines market is segmented into Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, and Respiratory. In 2017, the cardiovascular disease is estimated to be the dominating segment primarily due to the high proliferation of several cardiac disorders such as coronary artery disease, stroke, and hypertension.

Regional Analysis

North America to hold the largest market share in this industry, owning to the faster adoption of innovative technologies in developed countries such as U.S. and Canada. The existence of developed healthcare facilities, favorable reimbursement policies, and the easy availability of important as well as life-saving medicine has significantly enhanced the average life expectancy rates in North America. Additionally, the number of people that are over 65 to 70 years suffering several target ailments is increasing continually which is further anticipated to boost the geriatric medicines market during the forecast period.

Global Geriatric Medicine Market Size, Share Analysis By Region 2017

However, Asia-Pacific, on the other hand, is expected to dominate the global Geriatric Medicines Market during the forecast period. The major market share is primarily due to the substantial growth in the healthcare infrastructure, the launch of the number of branded and generic drugs, an increase in private and government healthcare spending, the increase in per head incomes, and growing number of geriatric population in countries such as Japan, China, and India.

Global Geriatric Medicine Market Study Objective

1. To forecast the market size of geriatric medicine market, along with describing and defining the market, in terms of volume and revenue.

2. Market analysis and forecast of geriatric medicine market on the basis of region, substrate and application or end-use industry.

3. To analyze and elaborate significant factors that will have major impact on the growth of geriatric medicine market, such as drivers, restraints, challenges and opportunities.

4. Regional analysis of geriatric medicine market, to induce market size of five global major regions, which include, Europe, North America, South America, Middle East & Africa and Asia Pacific.

5. Strategic analysis of micromarkets, in terms of individual prospects, opportunities, growth trends and their involvement in overall market.

6. To provide detailed analysis of competitive and strategic developments in the geriatric medicine market like new product launch, partnership & agreement, investment & expansion, and company merger & acquisitions.

7. Analysis of market opportunities for stakeholders, in order to provide a competitive landscape for global market players.

8. To profile major market players, and to analyze their market shares and essential competencies comprehensively.

Key Players

Major players operating in global Geriatric Medicine market include GlaxoSmithKline Plc, BoehringerIngelheim GmbH, Novartis AG, Bristol-Myers Squibb Company, Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories Inc., AstraZeneca plc, Merck & Company Inc., and Sanofi S.A. among others.

Global Geriatric Medicine Market Study Report Offer You!

The global market study report gives an idea about market size, share, stock, equity, investment and total price analysis. Also, the report provides comprehensively industry insights with all major factors such as market credit, allocation, demand, distribution, market scope, key players, end user & applications, provisions, livestock, commodities and industry economics analysis, future growth & forecast. The global market report includes all depth data like pre-market emphasis, market survey, market investment, industry advice, portfolio, finance, access, trade, market exploration, industry review and market predication & projection to develop effective strategies for optimizing their market position.